The CHMP recommended approval of the GLP-1 agonist liraglutide for type 2 diabetes in children aged 10 and older, but it recommended refusal of marketing authorization for osteoporosis agent romosozumab.
International Approvals …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
